Skip to Content

A2 (Zolpidem Extended Release 6.25 mg)

Pill imprint A2 has been identified as Zolpidem tartrate extended release 6.25 mg.

Zolpidem is used in the treatment of insomnia and belongs to the drug class miscellaneous anxiolytics, sedatives and hypnotics. Risk cannot be ruled out during pregnancy. Zolpidem 6.25 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Zolpidem tartrate extended release 6.25 mg A2
Zolpidem tartrate extended release 6.25 mg A2
Zolpidem tartrate extended release
Imprint:
A2
Strength:
6.25 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Miscellaneous anxiolytics, sedatives and hypnotics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
4 - Some potential for abuse
Manufacturer:
Actavis
National Drug Code (NDC):
00228-3481
Inactive Ingredients:
silicon dioxide
hypromelloses
lactose anhydrous
magnesium stearate
polyethylene glycol
tartaric acid
sodium bicarbonate
povidone
microcrystalline cellulose
sodium lauryl sulfate
magnesium silicate
titanium dioxide
methacrylic acid - methyl methacrylate copolymer (1:1)
triethyl citrate
polyvinyl alcohol

View Details Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide